Pondering The Future Of In-Person Meetings At The US FDA

Stakeholders believe virtual meetings should remain an option going forward, but that in-person sessions should still be convened in many cases.

Meeting room
The FDA could be ready to dust off its empty conference rooms and hold in-person meetings later this year. • Source: Alamy

Concerns may be rising among stakeholders about where the US Food and Drug Administration will place virtual meetings in its communications plans once the coronavirus pandemic ends.

Virtual sessions, i.e. those involving Zoom, WebEx or another video conferencing software, still should have a place on the FDA...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from US FDA Performance Tracker

More from Regulatory Trackers